Status:
UNKNOWN
Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 2
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Asthma
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The main objectives of the study are: -to unravel the importance of molecular phenotyping in predicting the response to classical anti-asthma treatment (inhaled corticosteroids) The investigators ha...
Eligibility Criteria
Inclusion
- steroid naive asthmatics
Exclusion
- viral/bacterial/fungal infection +fever(\<1month)
- asthma exacerbation (\<3months)
- other airway diseases (CF, ciliary dyskinesia, bronchiectasis)
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01224951
Start Date
January 1 2011
End Date
July 1 2018
Last Update
February 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Leuven
Leuven, Vlaams-Brabant, Belgium, 3000